Stay updated on TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial

Sign up to get notified when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:21:15.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a new study on the efficacy and safety of Tyrosine Kinase Inhibitors in combination with anti-PD-1 antibodies for treating MSS/pMMR metastatic colorectal adenocarcinoma, along with a revision update to v2.15.0. Notably, the previous detailed description of the study's purpose and methodology has been removed.
    Difference
    42%
    Check dated 2025-04-16T10:26:54.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:14:22.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:28:07.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:56:47.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T15:41:15.000Z thumbnail image

Stay in the know with updates to TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TKI + Anti-PD-1 in MSS/pMMR mCRC Clinical Trial page.